| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.81B | 9.93B | 9.48B | 8.87B | 9.00B | 8.62B |
| Gross Profit | 4.25B | 4.43B | 4.14B | 3.80B | 3.75B | 3.46B |
| EBITDA | 3.37B | 823.00M | 2.02B | 2.03B | 3.55B | 2.02B |
| Net Income | 2.12B | -98.00M | 1.05B | 1.01B | 4.22B | 996.00M |
Balance Sheet | ||||||
| Total Assets | 27.44B | 27.68B | 29.09B | 31.77B | 34.97B | 38.53B |
| Cash, Cash Equivalents and Short-Term Investments | 1.93B | 1.89B | 1.42B | 1.26B | 4.69B | 2.04B |
| Total Debt | 5.91B | 5.93B | 5.94B | 5.48B | 5.49B | 6.72B |
| Total Liabilities | 19.63B | 19.66B | 19.50B | 21.68B | 21.66B | 27.60B |
| Stockholders Equity | 7.74B | 7.94B | 9.52B | 10.02B | 13.26B | 10.82B |
Cash Flow | ||||||
| Free Cash Flow | 1.63B | 1.27B | 1.10B | 608.00M | 1.86B | 1.49B |
| Operating Cash Flow | 1.60B | 1.51B | 1.34B | 812.00M | 2.06B | 1.77B |
| Investing Cash Flow | 1.01B | 250.00M | -1.08B | -173.00M | 2.77B | -160.00M |
| Financing Cash Flow | -1.98B | -459.00M | -1.20B | -3.44B | -3.11B | 378.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $30.40B | 15.15 | 27.79% | 1.14% | ― | ― | |
73 Outperform | $13.18B | 23.01 | 30.44% | 1.90% | 9.64% | 15.87% | |
71 Outperform | $75.15B | 20.54 | 47.76% | 0.82% | 14.06% | 5.52% | |
71 Outperform | $64.04B | 43.42 | 6.87% | 1.01% | 17.17% | 19.12% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $24.62B | 22.82 | 10.99% | 0.77% | 17.87% | -9.35% |
On January 27, 2026, WTW completed its previously announced acquisition of Newfront Insurance Holdings, a San Francisco-based, top-40 U.S. insurance broker known for combining specialty sector expertise with advanced AI- and automation-enabled technology. The deal brings Newfront’s Business Insurance and Total Rewards units into WTW’s Risk & Broking and Health, Wealth & Career segments, respectively, immediately expanding WTW’s U.S. middle-market footprint and strengthening its presence in high-growth sectors such as technology, fintech and life sciences; with Newfront’s leadership, including co-founder and CEO Spike Lipkin, joining WTW to drive integration, client development and technology, the transaction is set to enhance WTW’s tech-enabled broking capabilities, competitive differentiation and ability to deliver integrated, data-driven solutions to clients of all sizes.
The most recent analyst rating on (WTW) stock is a Hold with a $347.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.
On January 7, 2026, Willis Towers Watson and its subsidiaries Trinity Acquisition plc and Willis North America Inc. entered into a $775 million unsecured delayed draw term loan facility arranged by JPMorgan Chase Bank to support WTW’s pending acquisition of Newfront Insurance Holdings, Inc., refinance existing debt and fund general corporate purposes including working capital, capital expenditures and permitted acquisitions. The three-year facility, which can be drawn in up to four tranches following completion of the Newfront deal and is subject to customary conditions, carries interest tied to Term SOFR or a base rate with margins and commitment fees dependent on WTW’s senior unsecured credit rating, and imposes standard covenants, reporting obligations and default provisions, with WTW and certain subsidiaries providing guarantees, underscoring the company’s commitment to disciplined balance-sheet management as it advances its expansion strategy in North America.
The most recent analyst rating on (WTW) stock is a Sell with a $318.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.
On December 22, 2025, Willis North America Inc., a subsidiary of Willis Towers Watson, completed a $1.0 billion public offering of senior unsecured notes, consisting of $700 million of 4.550% notes due 2031 and $300 million of 5.150% notes due 2036, fully and unconditionally guaranteed by several key Willis Towers Watson group entities in Ireland and the UK. The notes, which rank pari passu with the group’s existing senior unsecured debt and are effectively subordinated to any secured obligations, generated approximately $990 million in net proceeds that the company plans to use primarily to fund the proposed Newfront acquisition and repay $550 million of 4.400% senior notes due 2026, or, if the acquisition does not close, to fully repay the 2026 notes and redeem the 2036 notes, with any residual funds allocated to general corporate purposes.
The most recent analyst rating on (WTW) stock is a Buy with a $386.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.
On December 15, 2025, Willis North America Inc., a subsidiary of Willis Towers Watson, announced the pricing of a $1 billion offering of senior unsecured notes, with $700 million due in 2031 and $300 million due in 2036. The proceeds are intended to fund the Newfront acquisition and repay existing debt, with the offering not contingent on the acquisition’s closure.
The most recent analyst rating on (WTW) stock is a Buy with a $386.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.
On December 10, 2025, Willis Towers Watson (WTW) announced a definitive agreement to acquire Newfront Insurance Holdings, Inc., a San Francisco-based broker, for $1.3 billion. This acquisition, expected to close in the first quarter of 2026, will enhance WTW’s presence in the U.S. middle market and high-growth specialties such as technology, fintech, and life sciences. The integration of Newfront’s innovative technology and AI capabilities will complement WTW’s existing investments, accelerating its technology strategy and improving operational efficiency. The transaction is anticipated to be slightly dilutive to WTW’s adjusted EPS in 2026 but accretive in 2027, with expected cost synergies of $35 million by 2028.
The most recent analyst rating on (WTW) stock is a Buy with a $362.00 price target. To see the full list of analyst forecasts on Willis Towers Watson stock, see the WTW Stock Forecast page.